期刊文献+

S期激酶相关蛋白2在肝再生组织中的表达及其意义

Role of S-phase kinase-associated protein 2 in liver regeneration after partial hepatectomy
原文传递
导出
摘要 目的:观察S期激酶相关蛋白2(Skp2)在大鼠肝部分切除后残肝中的表达,探讨其在肝再生过程中的意义。方法:大鼠行70%肝部分切除术,分别在术后12,24,48,72,168 h,用免疫组化方法检测肝再生组织中Skp2及PCNA蛋白表达。结果:肝部分切除术后12,24,48,72 h,大鼠残肝组织中的Skp2及PCNA均表达明显增高,与相应各时间点的假手术组比较差异均有统计学意义(均P<0.01),且两者均在肝切除后48 h表达量达到最高峰,呈明显正相关(r=0.9085,P<0.05)。结论:Skp2在肝部分切除术后肝再生中起重要作用。 Objective: To observe the expression of S-phase kinase-associated protein 2 (Skp2) in the remnant liver tissue of rat with partial hepatectomy so as to determine its role in liver regeneration. Methods: Rats underwent 70% partial heptectomy and the their remnant liver tissues were collected at 12, 24, 48, 72 and 168 h after respectively pectively, after surgery. The expressions of Skp2 and proliferating cell nuclear antigen (PCNA) protein in the regenerating liver tissue were detected by immunohistochemical staining. Results: The expressions of Skp2 and PCNA in the remnant liver tissue of the rats with partial hepatectomy were all significantly higher than those of the sham operated rats at the observation time of 12, 24, 48 and 72 h, respectively after surgery (all P〈0.01). Both the Skp2 and PCNA expression reached their maximal levels at 48 h after hepatectomy and there was a significant correlation between them (r=0.9085, P〈0.05). Conclusion: Skp2 plays an important role in liver regeneration after partial hepatectomy.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2012年第1期77-80,共4页 China Journal of General Surgery
基金 青岛市卫生科技计划项目(2011-WSZD079)
关键词 肝切除术 肝再生 S期激酶相关蛋白质类 增殖细胞核抗原 大鼠 Hepatectomy Liver Regeneration S-Phase Kinase-Associated Proteins Proliferating Cell Nuclear Antigen Rats
  • 相关文献

参考文献15

  • 1Demetrick D J, Zhang H, Beach DH. Chromosomal mapping of the genes for the human CDK2/cyclin A-associated proteins p19 (SKP1A and SKP1B) and p45 (SKP2)[J]. Cytogenet Cell Genet, 1996, 73(1- 2):104-107.
  • 2Ganoth D, Bornstein G, Ko TK, et al. The cell-cycle regulatory protein Cksl is required for SCF (Skp2)-mediated ubiquitinylation of p27[J]. Nat Cell Biol, 2001, 3(3):321-324.
  • 3Sutterl u ty H, Chatelain E, Marti A, et al. p45SKP2 promotes p27Kipl degradation and induces S phase inquiescent cells[J]. Nat Cell Biol, 1999, 1(4):207-214.
  • 4Nakayama K, Nagahama H, Minamishima YA, et al. Targeted disruption of Skp2 results in accumulation of cyclin E and p27 (Kipl) polyplody and centrosome overduplication[J]. EMBO J, 2000, 19(9):2069-2081.
  • 5Hershko DD. Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer[J]. Cancer, 2008, 112(7):1415- 1424.
  • 6Gstaiger M, Jordan R, Lim M, et al. Skp2 is oncogenic and overexpressed in human cancers[J]. Proc Natl Acad Sci U S A, 2001, 98(9):5043-5048.
  • 7Uddin S, Ahmed M, Bavi P, et al. Bortezomib (Velcade) induces p27Kipl expression through S-phase kinase protein2 degradation in colorectal cancer[J]. Cancer Res, 2008, 68(9):3379-3388.
  • 8Ji P, Sun D, Wang H, et al. Disrupting Skp2-cyclin A interaction with a blocking peptide induces selective cancer cell killing[J]. Mol Cancer Ther, 2007, 6(2):684-691.
  • 9Higgins GM, Anderson RM. Experimental pathology of liver. I. Restoration of liver of white rat following partial surgical removal[J]. Arch Pathol, 1931, 12:186-202.
  • 10Carrano AC, Eytan E, Hershko A, et al. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27[J]. Nat Cell Biol, 1999, 1(4):193-199.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部